Get the Stockscreener App
2.37
7.78%
-0.20
After Hours:
2.37
Q 32 Bio Inc stock is traded at $2.37, with a volume of 109.60K.
It is down -7.78% in the last 24 hours and up +14.49% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.
See More
Previous Close:
$2.57
Open:
$2.55
24h Volume:
109.60K
Relative Volume:
0.48
Market Cap:
$28.91M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.42%
1M Performance:
+14.49%
6M Performance:
+44.51%
1Y Performance:
-94.94%
1-Day Range:
$2.35
$2.71
1-Week Range:
$2.35
$2.91
52-Week Range:
$1.345
$51.26
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
2.37 | 31.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Tick level data insight on Q32 Bio Inc. volatility2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Intraday pattern recognizer results for Q32 Bio Inc.Weekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Q32 Bio Inc. stock is a must watch in 2025July 2025 Action & Weekly Return Optimization Alerts - newser.com
Is Q32 Bio Inc. stock reversal real or fake2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com
Q32 Bio Inc expected to post a loss of $1.19 a shareEarnings Preview - TradingView
Price momentum metrics for Q32 Bio Inc. explainedEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Can Q32 Bio Inc. rally from current levelsJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Sentiment analysis tools applied to Q32 Bio Inc.Weekly Loss Report & Verified Momentum Stock Ideas - newser.com
How Q32 Bio Inc. stock reacts to oil pricesShare Buyback & Low Drawdown Momentum Ideas - newser.com
Trend analysis for Q32 Bio Inc. this weekSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Q32 Bio Inc. stock trendline breakdownProduct Launch & Real-Time Chart Pattern Alerts - newser.com
Is Q32 Bio Inc. stock cheap compared to fundamentalsJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
Key resistance and support levels for Q32 Bio Inc.July 2025 Levels & Proven Capital Preservation Tips - newser.com
What analysts say about Q32 Bio Inc stockMid Cap Growth Trends & Free High Yield Portfolio Picks - earlytimes.in
Why analysts upgrade Q32 Bio Inc. stockJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - fcp.pa.gov.br
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Q 32 Bio Inc Stock (QTTB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Aug 26 '25 |
Sale |
1.80 |
2,990 |
5,385 |
58,384 |
| Kalowski Lee | CFO and President |
Aug 26 '25 |
Sale |
1.80 |
4,240 |
7,636 |
49,010 |
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):